Inflammatory Markers and Adipokines Alter Adipocyte-derived ASP Production Through Direct and Indirect Immune Interaction

Abstract

Obesity and related metabolic diseases are associated with chronic low-grade inflammation, characterized by increased pro-inflammatory proteins. Several studies have demonstrated increases in acylation stimulating protein (ASP) and its precursor protein C3 in obesity, diabetes and dyslipidemia. To evaluate the effects of acute inflammatory factors and adipokines on ASP production and potential mechanisms of action, 3T3-L1 adipocytes were treated for 24 h with adipokines, cytokines, macrophage-conditioned media and direct co-culture with J774 macrophages. ASP and C3 in the media were evaluated in relation to changes in adipocyte lipid metabolism (cellular triglyceride stores). Leptin, adiponectin, IL-10, LPS and TNF-α increased ASP production (151%, 153%, 190%, 318%, 134%, P<0.05, respectively,). C5a and RANTES (Regulated and normal T cell expressed and secreted) decreased ASP production ( − 34%,  − 47%, P<0.05), which was also associated with a decrease in the precursor protein C3 ( − 39% to  − 51%, P<0.01), while keratinocyte chemoattractant (KC; murine IL-8 ortholog) had no effect on ASP and C3 secretion. By contrast, apelin, omentin and visfatin also decreased ASP ( − 27%,  − 49%,  − 22%, P<0.05), but without changes in precursor protein C3 secretion. Macrophage-conditioned media alone had little effect on C3 or ASP, while co-culture of adipocytes with macrophages markedly increased ASP and C3 production (272%, 167%, P<0.05). These in vitro results suggest various metabolic hormones and inflammatory factors can affect ASP production through increased precursor C3 production and/or by changing the rate of C3 conversion to ASP. As an adipokine, ASP could constitute a new link between adipocytes and macrophages.

Key words

adipocytokines - inflammation - obesity

*

^* Shared first author.

• References

• 1 Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808
• 2 Hotamisligil GS, Arner P, Caro JF et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415
• 3 Sartipy P, Loskutoff DJ. Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha. J Biol Chem 2003; 278: 52298-52306
• 4 Kim CS, Park HS, Kawada T et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 2006; 30: 1347-1355
• 5 Zeyda M, Stulnig TM. Adipose tissue macrophages. Immunol Lett 2007; 112: 61-67
• 6 Gao Y, Gauvreau D, Cianflone K. Hormone and pharmaceutical regulation of ASP production in 3T3-L1 adipocytes. J Cell Biochem 2010; 109: 896-905
• 7 Murray I, Sniderman AD, Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice. Am J Physiol 1999; 277: E474-E480
• 8 Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003; 1609: 127-143
• 9 Schrauwen P, Hesselink MK, Jain M et al. Acylation-stimulating protein: effect of acute exercise and endurance training. Int J Obes (Lond) 2005; 29: 632-638
• 10 Cianflone K, Maslowska M. Differentiation-induced production of ASP in human adipocytes. Eur J Clin Invest 1995; 25: 817-825
• 11 Kalant D, MacLaren R, Cui W et al. C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem 2005; 280: 23936-23944
• 12 Zhu S, Sun F, Li W et al. Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem 2011; 353: 305-313
• 13 Sommer G, Garten A, Petzold S et al. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 2008; 115: 13-23
• 14 Yang RZ, Lee MJ, Hu H et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290: E1253-E1261
• 15 Whitehead JP, Richards AA, Hickman IJ et al. Adiponectin – a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 264-280
• 16 Brochu-Gaudreau K, Rehfeldt C, Blouin R et al. Adiponectin action from head to toe. Endocrine 2010; 37: 11-32
• 17 Peake PW, Shen Y, Walther A et al. Adiponectin binds C1q and activates the classical pathway of complement. Biochem Biophys Res Commun 2008; 367: 560-565
• 18 Bluher M, Fasshauer M, Tonjes A et al. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 2005; 113: 534-537
• 19 Calcaterra V, De Amici M, Klersy C et al. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. Acta Biomed 2009; 80: 117-123
• 20 Dalmas E, Rouault C, Abdennour M et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr 2011; 94: 450-458
• 21 Belgardt BF, Bruning JC. CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci 2010; 1212: 97-113
• 22 Agrawal S, Gollapudi S, Su H et al. Leptin activates human B cells to secrete TNF-a, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol 2011; 31: 472-478
• 23 Tulipano G, Vergoni AV, Soldi D et al. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet. J Endocrinol 2004; 183: 289-298
• 24 Waage A. Tumour necrosis factor and septic shock. Lancet 1998; 351: 603
• 25 Sewter CP, Digby JE, Blows F et al. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol 1999; 163: 33-38
• 26 Medina EA, Stanhope KL, Mizuno TM et al. Effects of tumor necrosis factor alpha on leptin secretion and gene expression: relationship to changes of glucose metabolism in isolated rat adipocytes. Int J Obes Relat Metab Disord 1999; 23: 896-903
• 27 Rosenstock M, Greenberg AS, Rudich A. Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes. Diabetologia 2001; 44: 55-62
• 28 Hirokawa J, Sakaue S, Furuya Y et al. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J Biochem 1998; 123: 733-739
• 29 Winkler G, Lakatos P, Salamon F et al. Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabet Med 1999; 16: 207-211
• 30 Creely SJ, McTernan PG, Kusminski CM et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292: E740-E747
• 31 Vitseva OI, Tanriverdi K, Tchkonia TT et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008; 16: 932-937
• 32 Kopp A, Buechler C, Neumeier M et al. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity (Silver Spring) 2009; 17: 648-656
• 33 Yang Y, Lu HL, Zhang J et al. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes (Lond) 2006; 30: 439-446
• 34 Gerhardt CC, Romero IA, Cancello R et al. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001; 175: 81-92
• 35 Lu MM, Wang J, Pan HF et al. Increased serum RANTES in patients with systemic lupus erythematosus. Rheumatol Int 2012; 32: 1231-1233
• 36 Sewell DL, Nacewicz B, Liu F et al. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. J Neuroimmunol 2004; 155: 55-63
• 37 Ward PA. Functions of C5a receptors. J Mol Med (Berl) 2009; 87: 375-378
• 38 Suganami T, Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 2010; 88: 33-39
• 39 Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830
• 40 Harford KA, Reynolds CM, McGillicuddy FC et al. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc 2011; 70: 408-417
• 41 Maslowska M, Vu H, Phelis S et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 1999; 29: 679-686
• 42 Cianflone K, Zhang XJ, Genest Jr J et al. Plasma acylation-stimulating protein in coronary artery disease. Arterioscler Thromb Vasc Biol 1997; 17: 1239-1244
• 43 Wu Y, Zhang J, Wen Y et al. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril 2009; 91: 213-219
• 44 MacLaren RE, Cui W, Lu H et al. Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics 2010; 3: 3